Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.1
Condensed Balance Sheets - USD ($)
Dec. 31, 2020
Sep. 30, 2020
Current Assets    
Cash $ 673,963 $ 955,800
Prepaid expenses 47,222 96,472
Total Current Assets 721,185 1,052,272
Cash and marketable securities held in Trust Account 201,339,975 201,323,339
TOTAL ASSETS 202,061,160 202,375,611
LIABILITIES AND SHAREHOLDERS’ EQUITY    
Current liabilities – Accounts payable and accrued expenses 31,962 144,541
Warrant liabilities 31,375,000 25,500,000
Total Liabilities 31,406,962 25,644,541
Commitments and Contingencies
Ordinary shares subject to possible redemption, 16,565,419 and 17,173,106 shares at redemption value at December 31, 2020 and September 30, 2020, respectively 165,654,190 171,731,060
Shareholders’ Equity    
Preference shares, $0.0001 par value, 1,000,000 shares authorized; no shares issued and outstanding
Ordinary shares, $0.0001 par value, 150,000,000 shares authorized; 8,434,581 and 7,826,894 shares issued and outstanding (excluding 16,565,419 and 17,173,106 shares subject to possible redemption) at December 31, 2020 and September 30, 2020, respectively 843 783
Additional paid-in capital 23,640,745 17,563,935
Accumulated deficit (18,641,580) (12,564,708)
Total Shareholders’ Equity 5,000,008 5,000,010
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 202,061,160 $ 202,375,611